Nanocarriers in The Treatment of Head and Neck Cancer

- Authors: Ashish Garg1, Vaibhav Kumar S. Gawali2, Rupesh K. Gautam3, Rajeev K. Singla4, Sumel Ashique5
-
View Affiliations Hide Affiliations1 Department of P. G. Studies and Research in Chemistry and Pharmacy, Rani Durgavati University, Jabalpur (M.P.), 482001, India 2 Department of Internal Medicine/Nephrology, College of Medicine, University of Cincinnati, OH, USA 3 Department of Pharmacology, MM School of Pharmacy, Maharishi Markandeshwar University, Ambala Chandigarh Highway, Sadopur- Ambala-134007 (Haryana), India 4 Global Research and Publishing Foundation, New Delhi, India 5 Department of Pharmaceutics, Bharat Institute of Technology (BIT), School of Pharmacy, Meerut, UP, India
- Source: Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective , pp 255-279
- Publication Date: March 2023
- Language: English
Nowadays, Head and neck cancer is treated as a major disease worldwide. Several types of treatments are involved in this type of cancer, including immunotherapy, chemotherapy, radiation therapy, and surgery. Considering the clinical results from the past decades, these types of treatments resulted in no significant improvement in survival rates. To overcome these issues, versatile nanoparticles targeting selective tumors are considered. The targeted therapeutics based on the nanoparticle has a wide range of applications, such as photothermal therapy, radio sensitization, chemotherapeutic drug delivery, and gene splicing. In this study, we have discussed the recent advancement in targeted therapeutics based on nanoparticles for head and neck cancer. Further, we have described the targets in Head and Neck cancer and, thus, shared future perspectives.
-
From This Site
/content/books/9789815080506.chap9dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
